All American Association for Cancer Research news

7 days ago Drug shows early promise in treating patients with small-cell lung cancer - News-Medical-Net
8 days ago Syros to Present on SY-1425, Its First-Class Selective RARα Agonist, in Oral Plenary Session at AACR Hematologic Malignancies Conference - Business Wire
10 days ago Dangerous side effect of sleep loss - Bel Marra Health
10 days ago Vaccine-chemotherapy combination may improve survival for glioblastoma patients - News-Medical-Net
11 days ago Vaccine-chemotherapy combo offers hope for deadly brain cancer patients - New Kerala
15 days ago FDA approves drugs faster than Europe, study says - Northwest Herald
16 days ago PureTech Health Advances New Program Targeting Immunosuppressive Gamma Delta T Cells and Related Mechanisms - Business Wire
16 days ago Xavier University researchers develop new treatment to combat cancer - Louisiana Weekly
20 days ago Chi-Med Presented Pre-clinical Data for Fruquintinib and Sulfatinib at the American Association for Cancer Research Annual Meeting 2017 - Business Wire
20 days ago Prostate Cancer Task Force raising awareness of disease - FOX 43 Harrisburg
20 days ago Word on the Hill: Dine Out and Donate - Roll Call
20 days ago FDA approves more drugs, and faster, than Europe - CTV News
20 days ago Lung cancer patients could soon get new drug on NHS - chroniclelive
21 days ago Low-dose aspirin can reduce risk of death from cancer, research says - FOX 43 Harrisburg
21 days ago MSU and Venn Therapeutics develop promising therapy to delay B16 melanoma tumor growth - News-Medical-Net
21 days ago FDA approves more drugs, and faster, than Europe, study says - Boston Globe
21 days ago FDA Approves More Drugs, and Faster, Than Europe: Study - NBC Dallas Fort Worth
21 days ago FDA Approves More Drugs, and Faster, Than Europe: Study - NBC Bay Area
21 days ago FDA approves more drugs, and faster, than Europe, study says - NBC 2 Fort Myers
21 days ago FDA approves more drugs, and faster, than Europe, study says - KTVN Reno
21 days ago FDA approves more drugs, and faster, than Europe, study says - Hawaii News Now
21 days ago FDA approves more drugs, and faster, than Europe, study says - WSB-TV 2 Atlanta
21 days ago FDA approves more drugs, and faster, than Europe, study says - KFJX Pittsburg
21 days ago FDA approves more drugs, and faster, than Europe, study says - WDAM-TV Hattiesburg
21 days ago FDA approves more drugs, and faster, than Europe, study says - ABC 7 Gulfshore News
21 days ago FDA approves more drugs, and faster, than Europe, study says - WECT 6 Wilmington
21 days ago FDA approves more drugs, and faster, than Europe, study says - WSFA 12 Montgomery
21 days ago FDA approves more drugs, and faster, than Europe, study says - 14 WFIE Evansville
21 days ago FDA approves more drugs, and faster, than Europe, study says - 9&10 News Cadillac
21 days ago FDA approves more drugs, and faster, than Europe, study says - KXXV Waco
21 days ago Low-Dose Aspirin Can Reduce Risk of Death From Cancer, Research Says - FOX40 Sacramento
21 days ago Low-dose aspirin can reduce risk of death from cancer, research says - Q13 FOX Seattle
21 days ago Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030 - News-Medical-Net
21 days ago Drug May Triple Survival for Lung Cancer Patients - Newsmax
21 days ago Length of Telomeres Could Predict Cancer Risk - Newsmax
21 days ago ‘Sci-fi’ cancer therapy fights brain tumours - asianage
21 days ago Speaking of Cancer Research - The Scientist
22 days ago Length of chromosomes' protective tips could predict cancer risk - CTV News
22 days ago OSE Immunotherapeutics a présenté des nouvelles données sur OSE-172 (Effi-DEM), son nouveau checkpoint inhibiteur bloquant les cellules myéloïdes suppressives tout en induisant une réponse T mémoire anti-tumorale - Business Wire
22 days ago OSE Immunotherapeutics Presented New Data at AACR* Annual Meeting 2017 on OSE-172 (Effi-DEM), Company’s Checkpoint Inhibitor Blocking Suppressive Myeloid Cells and Inducing Antitumoral Potent T Memory Response - Business Wire
22 days ago Billy Baker wins American Society of News Editors award for writing excellence - Boston Globe
22 days ago Low-dose aspirin can reduce risk of death from cancer, research says - WTKR Norfolk
22 days ago Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 AACR Annual Meeting - Business Wire
22 days ago 'Sci-fi' cancer therapy fights brain tumors - Jefferson City News Tribune
22 days ago Low-dose aspirin can reduce risk of death from cancer, research says - News 8000
22 days ago Low-dose aspirin can reduce risk of death from cancer, research says - KTXS Abilene
22 days ago Low-dose aspirin can reduce risk of death from cancer, research says - KECI Missoula
22 days ago Low-dose aspirin can reduce risk of death from cancer, research says - WCYB 5 Tri-Cities
22 days ago Low-dose aspirin can reduce risk of death from cancer, research says - KRDO Colorado Springs
22 days ago Low-dose aspirin can reduce risk of death from cancer, research says - KRCR TV Redding

Create a custom search

News search supports Google type search formatting and the use of complex boolean. Wrap terms in double quotes for exact phrase matching. Click + to add multiple news search terms to this topic.